Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 VaccineHyer, Randall NThe cancer journal (Sudbury, Mass.), 2022-03, Vol.28 (2), p.146-150 [Periódico revisado por pares]United States: Lippincott Williams & WilkinsSem texto completo |
|
2 |
Material Type: Artigo
|
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 yearsHyer, Randall N ; Janssen, Robert SVaccine, 2019-09, Vol.37 (39), p.5854-5861 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populationsHirst, Alex ; Hyer, Randall N. ; Janssen, Robert S.Vaccine, 2021-07, Vol.39 (33), p.4733-4741 [Periódico revisado por pares]Kidlington: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health CrisisBloom, David E ; Cadarette, Daniel ; Ferranna, Maddalena ; Hyer, Randall N ; Tortorice, Daniel LHealth affairs (Millwood, Va.), 2021-03, Vol.40 (3), p.410-6 [Periódico revisado por pares]United States: The People to People Health Foundation, Inc., Project HOPETexto completo disponível |
|
5 |
Material Type: Artigo
|
Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adultsHyer, Randall ; McGuire, Darren K. ; Xing, Biao ; Jackson, Sam ; Janssen, RobertVaccine, 2018-05, Vol.36 (19), p.2604-2611 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
NCRP Program Area Committee 7: Radiation Education, Risk Communication, Outreach, and PolicyHyer, Randall NHealth physics (1958), 2018-02, Vol.114 (2), p.259-260 [Periódico revisado por pares]United States: Lippincott Williams & Wilkins Ovid TechnologiesSem texto completo |
|
7 |
Material Type: Artigo
|
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscapeDas, Rituparna ; Hyer, Randall N. ; Burton, Paul ; Miller, Jacqueline M. ; Kuter, Barbara J.Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2153532-2153532 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
|
8 |
Material Type: Artigo
|
Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment"Das, Rituparna ; Hyer, Randall N. ; Burton, Paul ; Miller, Jacqueline M. ; Kuter, Barbara J.Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2195333-2195333 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
|
9 |
Material Type: Artigo
|
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysisAwad, Ahmed M. ; Ntoso, Adu ; Connaire, Jeffrey J. ; Hernandez, German T. ; Dhillon, Kiranjit ; Rich, Lisa ; Henderson, Heather ; Lynn, Robert ; Hyer, Randall N. ; Xie, Fang ; Erby, Kimberly ; Janssen, Robert S.Vaccine, 2021-06, Vol.39 (25), p.3346-3352 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Synergies resulting from a systems biology approach: integrating radiation epidemiology and radiobiology to optimize protection of the public after exposure to low doses of ionizing radiationDainiak, Nicholas ; Feinendegen, Ludwig E. ; Hyer, Randall N. ; Locke, Paul A. ; Waltar, Alan E.International journal of radiation biology, 2018-01, Vol.94 (1), p.2-7 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |